Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Valerio Therapeutics SA banner

Valerio Therapeutics SA
F:C4X

Watchlist Manager
Valerio Therapeutics SA Logo
Valerio Therapeutics SA
F:C4X
Watchlist
Price: 0.57 EUR -0.52% Market Closed
Market Cap: €87.8m
Write Note Create Alert Ask AI

Wall St Price Targets

C4X Price Forecast
No price targets yet

We don't have analyst price targets for C4X yet.

C4X Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for C4X yet.

Valerio Therapeutics SA Competitors:
Price Targets

Revenue
Forecast

-2% / Year
Past Growth
741% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat
-2% / Year
Past Growth
741% / Year
Estimated Growth
Estimates Accuracy
6%
Average Beat

Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 741%.

What are analyst estimates?

Gross Profit
Forecast

-3% / Year
Past Growth
-38% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-3% / Year
Past Growth
-38% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Gross Profit has been -3%. The projected CAGR for the next 3 years is -38%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

What are analyst estimates?

Continue C4X Research

Summary
C4X intrinsic value, competitors valuation, and company profile.
DCF Valuation
C4X stock valuation using Discount Cash Flow valuation method.
Relative Valuation
C4X stock valuation using valuation multiples.
Wall St Estimates
C4X price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
C4X stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Valerio Therapeutics SA listings:
LSE • EUR
0NWK
 PAR • EUR
ALVIO
 XMUN • EUR
C4X
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is C4X's stock price target?
Not Available

C4X does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Valerio Therapeutics SA?
Projected CAGR
741%

Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 741%.

What is the Gross Profit forecast for Valerio Therapeutics SA?
Projected CAGR
-38%

Over the last 14 years, the compound annual growth rate for Gross Profit has been -3%. The projected CAGR for the next 3 years is -38%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.